Open original FDA record ↗Recall record
- FDA identifier
- Z-2745-2018
- Company in FDA record
- Tosoh Bioscience Inc
- FDA record creation date
- Aug 11, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
HbAE is known to interfere with the HbA1c assay on the current version of software, Ver. 5.23. Customers should exercise caution when reviewing chromatograms and ensure that Flag 43 is enabled on their device to avoid reporting invalid test results in the presence of HbAE.
Source facts
- Action
- The firm issued an Urgent Medical Device Recall letter to its affected customers on June 6, 2018. In the notice, Tosoh is currently investigating a resolution to this issue to eliminate interference from hemoglobin variants. In the interim, customers should carefully review the chromatography to determine whether or not a variant peak is detected and follow the recommendations included in the letter. Customers were asked to complete and return the attached Acknowledgement Form and the flag setting confirmation to Tosoh Bioscience, Inc., within 14-days of receiving this notification by FAX, email, or postal mail as indicated on the form. If you have obtained unexpected test results or received any complaints of illness or adverse events associated with the use of the analyzer, please contact Tosoh Technical Support 24 hours a day, seven days a week at (800) 248-6764.
- Initiated
- 2018-06-06
- Root cause
- Software design
- Terminated
- 2021-02-09
- Distribution
- Worldwide Distributed - US Nationwide. and the countries of Foreign distribution to Brazil, Caribbean, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Panama, Peru, and Uruguay.
- Recall number
- Z-2745-2018
- Recall status
- Terminated
- CDRH record ID
- 164973
- FDA record created
- 2018-08-11
- Recall event number
- 80257